• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Monday, February 6, 2023
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS

Antibiotic study inspires new pathways in heart valve research

Bioengineer by Bioengineer
October 29, 2013
in NEWS
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
 
“Very little is known about the intracellular dynamics between genes, proteins and the metabolic pathways that guide either normal processes or give rise to abnormalities,” said Grande-Allen. “Accumulative efforts in our lab involve investigations into valve cell morphology and disease from a more mechanical perspective. Specifically, we look for cues as to how alterations to cells and cellular environments are driven by mechanical stress of the pumping heart over many years.”
 
In a unique twist of fate, Grande-Allen, graduate student Dena Wiltz, and undergraduate student Aditya Kumar found that Gentamicin, an aminoglycosidic antibiotic used to treat many types of bacterial infections, significantly reduced the number and size of calcific nodules formed by valvular interstitial cells.
 
The research, which was detailed in the journal Cardiovascular Engineering and Technology, was initially spurred by the lab’s examination of various antibiotics for the occasional prevention of bacterial infections in cell cultures. 
 
“Contamination of cell cultures is a consistent issue for researchers. Impurities not only adversely affect results, but vast amounts of time and money can be spent managing bacterial contaminates,” said Wiltz, a sixth-year graduate student in the Grande-Allen lab at Rice’s BioScience Research Collaborative whose research in valve disease is supported by a grant from Baylor College of Medicine. “Gentamicin is widely used for the in vitro prevention of cell and tissue culture contamination, but it has been reported to affect calcium levels in various cell types. So we decided to add it to our cultures – not to prevent contamination so much as to see if it regulated calcium mineralization by valve cells.”
 
Their investigations paid off. “Not only did we find that dose-dependent increases of Gentamicin caused alterations to cellular mineralization, but the findings, along with a literary investigation, spurred insight into the roles cellular components, such as lipids and mitochondria, might play in the development of pathological calcification,” added Kumar, who is a Rice senior and co-author on the research paper. He has been a member of the Grande-Allen group since the summer of his freshman year.
 
Aortic valve tissue is made up of trilayered connective tissues, and Grande-Allen and her students apply engineering analysis to decode how individual parts of this complex cooperate, respond to cellular signals, and are influenced by overall valvular function, growth and the evolution of abnormalities.
 
“Through a bottom up approach, we are looking at how valvular interstitial cells – the primary cells within these tissue layers – interact both biologically and mechanically with their surrounding environments,” explained Grande-Allen. “Although Gentamicin has limited clinical use due to its toxic side effects, our results might prove to be useful in connecting these processes, and ultimately in the development of promising pharmaceuticals that curb the progression of heart-valve disease.”
 
The research was also supported by an NIH grant from the National Heart, Lung, and Blood Institute (NHLBI).
 

Story Source:

The above story is reprinted from materials provided by Rice University. The original article was written by Shawn Hutchins.

 

Tags: BioengineeringRice University
Share12Tweet8Share2ShareShareShare2

Related Posts

$1.6M gift to Markey Cancer Center will establish endowed chair in gynecologic oncology

$1.6M gift to Markey Cancer Center will establish endowed chair in gynecologic oncology

February 6, 2023
Dr. Eduard Vasilevskis

VUMC’s ‘Shed-MEDS’ protocol can reduce risk of drug interactions in older people

February 6, 2023

Scientists pinpoint protein that helps cancer-causing viruses evade immune response

February 6, 2023

Seven new species of whitefish described in Central Switzerland

February 6, 2023
Please login to join discussion

POPULAR NEWS

  • Jean du Terrail, Senior Machine Learning Scientist at Owkin

    Nature Medicine publishes breakthrough Owkin research on the first ever use of federated learning to train deep learning models on multiple hospitals’ histopathology data

    65 shares
    Share 26 Tweet 16
  • Metal-free batteries raise hope for more sustainable and economical grids

    41 shares
    Share 16 Tweet 10
  • First made-in-Singapore antibody-drug conjugate (ADC) approved to enter clinical trials

    58 shares
    Share 23 Tweet 15
  • One-pot reaction creates versatile building block for bioactive molecules

    37 shares
    Share 15 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

$1.6M gift to Markey Cancer Center will establish endowed chair in gynecologic oncology

VUMC’s ‘Shed-MEDS’ protocol can reduce risk of drug interactions in older people

Scientists pinpoint protein that helps cancer-causing viruses evade immune response

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 43 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In